Statement Re Share Price Movement
Immediate Release: Tuesday 6th January 2009
Toumaz Holdings Limited
(`Toumaz Holdings', the `Company' or the `Group')
Statement Re Share Price Movement
Toumaz Holdings notes the recent increase in the Company's share price, which
it attributes to recent press speculation. The Group confirms it does not
anticipate announcing a joint venture deal in the immediate future.
In line with recent announcements made by the Group, the push to
commercialisation of its investments continues into 2009. Toumaz Technology
Limited (`Toumaz Technology') has recently secured two significant agreements.
As part of the previously announced engagement with Cardinal Health Inc., the
first of a series of pilot studies on the performance of the key Sensium(tm)
technology has been approved by ethics and the Medicines and Healthcare
products Regulatory Agency (`MHRA') and is about to begin in a UK. In addition,
Texas Instruments Inc. has accepted Sensium(tm) as a fully qualified product and
sales will begin shortly in the medical device sector.
For further information please contact:
Guy Spelman
Toumaz Holdings Limited
Tel: +44 7767 338 967
Rose Herbert/
Charles Cunningham/
Sam Smith
FinnCap
Tel: 020 7600 1658
Vikki Krause
Hansard Group
Tel: +44 207 245 1100
END